Is the International Prognostic Index for aggressive lymphomas useful for low-grade lymphoma patients? Applicability to stage III-IV patients. The GOELAMS Group, France. [electronic resource]
- Annals of oncology : official journal of the European Society for Medical Oncology 1997
- 49-52 p. digital
Publication Type: Clinical Trial; Journal Article; Multicenter Study
0923-7534
Humans L-Lactate Dehydrogenase--blood Lymphoma, Non-Hodgkin--mortality Middle Aged Neoplasm Staging Predictive Value of Tests Prognosis Prospective Studies Severity of Illness Index Survival Analysis Treatment Outcome